KolmarBNH Co Ltd
KOSDAQ:200130
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mainz Biomed NV
NASDAQ:QUCY
|
DE |
KolmarBNH Co Ltd
Inventory
KolmarBNH Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KolmarBNH Co Ltd
KOSDAQ:200130
|
Inventory
₩74.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
AmorePacific Corp
KRX:090430
|
Inventory
₩480.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Amorepacific Group
KRX:002790
|
Inventory
₩539.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Cosmax Inc
KRX:192820
|
Inventory
₩270.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Inventory
₩832.4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Inventory
₩452.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
25%
|
|
KolmarBNH Co Ltd
Glance View
KolmarBNH Co., Ltd. engages in the provision of manufacturing medicaments. The company is headquartered in Sejong, Sejong. The company went IPO on 2014-07-23. The firm mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The firm also produces cosmetics using natural extracts, and other pharmaceuticals. The firm also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
See Also
What is KolmarBNH Co Ltd's Inventory?
Inventory
74.5B
KRW
Based on the financial report for Sep 30, 2025, KolmarBNH Co Ltd's Inventory amounts to 74.5B KRW.
What is KolmarBNH Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
13%
Over the last year, the Inventory growth was 0%. The average annual Inventory growth rates for KolmarBNH Co Ltd have been -5% over the past three years , 9% over the past five years , and 13% over the past ten years .
